These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2862251)

  • 1. Dopamine receptor agonistic activities of R- and S-enantiomers of 4-hydroxy-2-di-n-propylaminoindan in cat hearts.
    Ilhan M; Flynn JR; Long JP; Bhatnagar RK; Cannon JG
    J Pharm Pharmacol; 1985 May; 37(5):364-5. PubMed ID: 2862251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and dopaminergic activity of (R)- and (S)-4-hydroxy-2-(di-n-propylamino)indan.
    Cannon JG; Dushin RG; Long JP; Ilhan M; Jones ND; Swartzendruber JK
    J Med Chem; 1985 Apr; 28(4):515-8. PubMed ID: 3981545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic structure-activity relationships of 2-aminoindans and cardiovascular action and dopaminergic activity of 4-hydroxy, 5-methyl, 2-di-n-propylaminoindan (RD-211).
    Ma SX; Long JP; Flynn JR; Leonard PA; Cannon JG
    J Pharmacol Exp Ther; 1991 Feb; 256(2):751-6. PubMed ID: 1671601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analysis of 2-aminoindans and 2-(aminomethyl)indans in relation to their central dopaminergic effects and a dynamic dopamine receptor concept.
    Wikström H; Lii JH; Allinger NL
    J Med Chem; 1987 Jul; 30(7):1115-20. PubMed ID: 3599018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a potential dopaminergic prodrug moiety in several ring systems.
    Cannon JG; Furlano DC; Dushin RG; Chang YA; Baird SR; Soliman LN; Flynn JR; Long JP; Bhatnagar RK
    J Med Chem; 1986 Oct; 29(10):2016-20. PubMed ID: 3761320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity.
    Hacksell U; Arvidsson LE; Svensson U; Nilsson JL; Wikström H; Lindberg P; Sanchez D; Hjorth S; Carlsson A; Paalzow L
    J Med Chem; 1981 Apr; 24(4):429-34. PubMed ID: 7265130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions.
    Arnerić SP; Long JP
    J Pharm Pharmacol; 1984 May; 36(5):318-21. PubMed ID: 6145768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis.
    Timmerman W; Tepper PG; Dijkstra D; Stoelwinder H; Grol CJ; Westerink BH; Horn AS
    Eur J Pharmacol; 1991 Jun; 199(2):145-51. PubMed ID: 1683287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of dopamine agonists.
    Cannon JG
    Annu Rev Pharmacol Toxicol; 1983; 23():103-29. PubMed ID: 6347047
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.
    Bøgesø KP
    J Med Chem; 1983 Jul; 26(7):935-47. PubMed ID: 6134833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resorcinol congeners of dopamine derived from benzocycloheptene and indan.
    Cannon JG; Pease JP; Hamer RL; Ilhan M; Bhatnagar RK; Long JP
    J Med Chem; 1984 Feb; 27(2):186-9. PubMed ID: 6319700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ha-117 and Ha-118 are potent dopamine receptor agonists.
    Ilhan M; Long JP; Cannon JG
    J Pharm Pharmacol; 1984 Mar; 36(3):213-4. PubMed ID: 6144764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally restricted congeners of dopamine derived from 2-aminoindan.
    Cannon JG; Perez JA; Bhatnagar RK; Long JP; Sharabi FM
    J Med Chem; 1982 Dec; 25(12):1442-6. PubMed ID: 7154005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantiomers of indacrinone: a new approach to producing an isouricemic diuretic.
    Blaine EH; Fanelli GM; Irvin JD; Tobert JA; Davies RO
    Clin Exp Hypertens A; 1982; 4(1-2):161-76. PubMed ID: 7074983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aprindine and lidocaine on transmembrane potentials and radioactive K efflux in different cardiac tissues.
    Carmeliet E; Verdonck F
    Acta Cardiol; 1974; Suppl 18():73-90. PubMed ID: 4547403
    [No Abstract]   [Full Text] [Related]  

  • 18. Indacrinone: natriuretic and uricosuric effects of various ratios of its enantiomers in healthy men.
    Vlasses PH; Rotmensch HH; Swanson BN; Irvin JD; Johnson CL; Ferguson RK
    Pharmacotherapy; 1984; 4(5):272-7. PubMed ID: 6504708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake.
    Bøgesø KP; Christensen AV; Hyttel J; Liljefors T
    J Med Chem; 1985 Dec; 28(12):1817-28. PubMed ID: 2999402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of clidanac, a potent anti-inflammatory drug, on mitochondrial respiration: a consideration on the uncoupling activity of optical enantiomers.
    Kawai K; Shiojiri H; Fukushima H; Nozawa Y; Hasegawa J; Nozaki M; Tsurumi K; Fujimura H
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):399-406. PubMed ID: 6334337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.